Abstract:Background MicroRNAs, as small non-coding RNAs, play an important role in tumorigenesis. MiR-483-5p was found to have a significant increase as a diagnostic biomarker of nasopharyngeal carcinoma (NPC), not only in plasma from NPC patients but also in tumor cell lines and biopsy tissues in our previous study. However, its function and mechanism in NPC are still unclear. Methods Tissue microarray including 178 primary NPC and 35 adjacent non-cancerous nasopharyngeal mucosal tissues was used to further validate the overexpression of miR-483-5p. Wound healing and invasion assays were conducted to verify its biological function. RNA sequencing (RNA-seq) and dual-luciferase reporter assay was performed to explore its target, and it was verified in fresh biopsy tissues from 23 NPC patients and 9 patients with chronic nasopharyngitis. Results MiR-483-5p was highly expressed in NPC tissues than in adjacent non-cancerous tissues. It was found to have a significant correlation with poor overall survival (OS) [hazard ratio (HR) = 2.89, 95% confidence interval (CI) = 1.00–8.35, p = 0.041] and progression-free survival (PFS) (HR = 1.95, 95%CI = 1.06–3.60, p = 0.029) of NPC patients. Silencing of its expression inhibited the migratory and invasive capacities of NPC cells in vitro . EGR3 (early growth response 3) was identified as a direct target, and inhibiting miR-483-5p expression markedly enhanced the expression of EGR3 at both the mRNA and protein levels. Besides, a significant decrease of EGR3 expression was found in fresh biopsy tissues from NPC patients, in contrast to miR-483-5p expression. Furthermore, directly decreasing the expression of EGR3 could enhance the migration and invasion of NPC cells. Conclusion The newly identified miR-483-5p/ EGR3 pathway provides further insights into the development and metastasis of NPC and may provide a potential therapeutic target for NPC treatment in order to improve survival of NPC patients.

MiR-34b-3 and Mir-449A Inhibit Malignant Progression of Nasopharyngeal Carcinoma by Targeting Lactate Dehydrogenase A

Identification of Mir-143 As A Tumour Suppressor in Nasopharyngeal Carcinoma Based on Microrna Expression Profiling

MiR-34c Suppresses Tumor Growth and Metastasis in Nasopharyngeal Carcinoma by Targeting MET.

Upregulation of MiR-155 in Nasopharyngeal Carcinoma is Partly Driven by LMP1 and LMP2A and Downregulates a Negative Prognostic Marker JMJD1A.

MicroRNA-483-5p Predicts Poor Prognosis and Promotes Cancer Metastasis by Targeting EGR3 in Nasopharyngeal Carcinoma

MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma

MiR-138 Suppressed Nasopharyngeal Carcinoma Growth and Tumorigenesis by Targeting the CCND1 Oncogene

MicroRNA‑342‑3p Suppresses Proliferation and Invasion of Nasopharyngeal Carcinoma Cells by Directly Targeting Cdc42

Mir-214 Promotes Tumorigenesis by Targeting Lactotransferrin in Nasopharyngeal Carcinoma.

Mir-9 Targets CXCR4 and Functions As a Potential Tumor Suppressor in Nasopharyngeal Carcinoma.

miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.

Microrna-141 is Involved in a Nasopharyngeal Carcinoma-Related Genes Network.

MicroRNA-19b-3p Regulates Nasopharyngeal Carcinoma Radiosensitivity by Targeting TNFAIP3/NF-κB Axis

Mir-145 Inhibits Metastasis By Targeting Fascin Actin-Bundling Protein 1 In Nasopharyngeal Carcinoma

Downregulated Mir-150-5p in the Tissue of Nasopharyngeal Carcinoma

MicroRNA‑30a Regulates Cell Proliferation, Migration, Invasion and Apoptosis in Human Nasopharyngeal Carcinoma Via Targeted Regulation of ZEB2.

MiR-451 Inhibits Cell Growth and Invasion by Targeting MIF and is Associated with Survival in Nasopharyngeal Carcinoma

MicroRNA Deregulation and Pathway Alterations in Nasopharyngeal Carcinoma.

MiR-663, a Microrna Targeting P21waf1/cip1, Promotes the Proliferation and Tumorigenesis of Nasopharyngeal Carcinoma

miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma.

MicroRNA-30a Promotes Invasiveness and Metastasis in Vitro and in Vivo Through Epithelial-Mesenchymal Transition and Results in Poor Survival of Nasopharyngeal Carcinoma Patients.